Live respiratory syncytial virus attenuated by M2-2 deletion and stabilized temperature sensitivity mutation 1030s is a promising vaccine candidate in children

Written By
McFarland EJ, Karron RA, Muresan P, Cunningham CK, Libous J, Perlowski C, et al.
Back to top